daratumumab,dexamethasone,carfilzomib,lenalidomide
janssen,amgen
['krd', 'gem-cesar', 'dara-krd']
3.3% infection-related deaths with dara-krd in smoldering #myeloma. follow-up not long enough for spms (2.2% fatal spms in gem-cesar!!). given dismal 4-year sustained mrd-neg in gem-cesar (23%), long-term follow up need to see if mrd-neg rate holds up after rx stops!! #ash22 
Hematologist/Cancer Doctor/Clinical Researcher @ColumbiaCancer 
#Myeloma #Amyloidosis
Asst. Prof @ColumbiaMed
Host @BloodCancerTalk
COI: https://t.co/du0rVN9gca